InvestorsHub Logo
Followers 42
Posts 8476
Boards Moderated 2
Alias Born 11/14/2019

Re: None

Sunday, 10/02/2022 10:44:05 AM

Sunday, October 02, 2022 10:44:05 AM

Post# of 20435
CEO on Twitter - It sure is nice that GC gets it done and has a good presence on Twitter, I wonder if TOMDF follow this board.

Todos have been good enough to keep us posted with their plans going forward. Being a relatively new shareholder I think that it's getting a bit confusing with all of the plans the company has versus what has actually already transpired. After a while promised don't make the shareprice stronger since a lot of old news and hopes are already built-in to the shareprice.

I'm getting confused as to what is actually really being done NOW ....we have Tollovid now as a online revenue stream, testing is confusing in that some tests are approved and being used somewhere and clinics are planned , but is testing bringing in revenue now?

And that's another thing. What is actually in clinical testing now as we speak?

Are there other revenue streams that are actually bringing in money Now?

I think most of the action/volume on the shareprice looks like micro penny flippers and HFT's so the shareprice is vulnerable....Press Releases with future plans no longer move it or strengthen it.

I have read the news but still confused.

So the question is are there other or any revenue streams besides Tollovid?

And are we currently actively in a clinical trial?